CuroNZ Limited
PrivateLast Round
Grant
Dec 11, 2015
Total Funding Raised
$960,000
Company Overview
CuroNZ Limited operates in Healthcare & Life Sciences and is based in New Zealand. Its latest recorded funding round was a Grant round in December 2015.
CuroNZ Limited is a clinical-stage biotechnology company that develops a platform of peptide drugs for the treatment of severe neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CuroNZ Limited Comparables
Compare CuroNZ Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genervon Biopharmaceuticals | 78% | |
| EpilepsyGTx | 73% | |
| Ovid Therapeutics Inc. | 72% |
For institutional investors. Book with your work email.
CuroNZ Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 11, 2015 | ||||
| Grant | Oct 14, 2013 | ||||
| Debt | Jul 8, 2011 | ||||
| Angel | May 1, 2010 | ||||
| Seed | Dec 18, 2009 |
For institutional investors. Book with your work email.
CuroNZ Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Callaghan Innovation | Grant |
| National MS Society | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Monthly visitors grew 361% MoM, reaching 6.8K.
- Oct 14, 2013
$540K grant received from the National MS Society.
For institutional investors. Book with your work email.
CuroNZ Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CuroNZ Limited's valuation, stock price, and market status.
Is CuroNZ Limited a public or private company?
CuroNZ Limited is a private company.
What is the current stock price of CuroNZ Limited?
CuroNZ Limited is a private company, so its shares have no public market price. Caplight tracks CuroNZ Limited's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CuroNZ Limited worth (valuation)?
Valuation information for CuroNZ Limited is not publicly available.
Can I buy CuroNZ Limited stock?
CuroNZ Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CuroNZ Limited's last funding round?
CuroNZ Limited's most recent funding round was Grant on December 11, 2015.
Who are the main investors in CuroNZ Limited?
Key investors in CuroNZ Limited include Callaghan Innovation, National MS Society.
Will CuroNZ Limited IPO soon?
No public IPO plans have been announced for CuroNZ Limited.
How can I track CuroNZ Limited secondary market activity?
Caplight tracks bids, offers, and trades in CuroNZ Limited's shares on secondary markets.